This dog eats muffins …
… and eggs!
Yeesh. It has been 4 days since the last Palladia dose. And Vodka’s appetite is nowhere close to normal. As of yesterday, he was still poopy (in terms of quality, not frequency :)) and a bit nauseous. And he seems to have a mental block about eating most meats!!! Not interested in turkey [...]
Food is exciting again!
After a couple of scary days, Vodka’s belly seems to be settling down. About time too. It was pretty unsettling to see him turn his face away from food. This is the same dog that climbs on counters to steal food, gets into a milk box to drink up cartons of milk and buttermilk, even [...]
The side effects start rolling in :(
After 2 weeks of a fabulous response to Palladia, Vodka’s body was finally hit by side effects. Over the last week, he’s been getting increasingly picky about food - he’s been nauseous, gets turned off by various smells, eats a little bit and then walks away All this from the chowhound who has never [...]
It fell off!!!
Remember the cutaneous tumor on Vodka’s back? The first one that came back in late January? The one that slowly grew in size over the last couple of months? The one that we shaved around so we could spray NasalCrom to reduce the histamine release? The one that I hated looking at (I hate all [...]
One tumor becomes 2, and that seems to be a good thing!
So, the hyper-Vodka visited his pals at ACS today. Super-hyper-Vodka. So much so that Dr.Gillings rolled her eyes and asked “Does he *ever* take a break?!” Hmm … yesss, sometimes … like when he sleeps? Or when he’s chased the ball till he truly drops?
Anyway, she was pretty happy with his response to [...]
5 days in …
Vodka had his third dose of Palladia (a Phase III clinical trial drug) this morning. So far, other than one instance of soft stools, he hasn’t had any side effects. Plus, the drug seems to be working so far. The internal mass in the prescapular lymph region definitely feels smaller - how do we know? [...]
Day 1 of a clinical trial drug
Today, we started Vodka on a a drug that is in Phase III clinical trial. For those biochem geeks, this is a receptor tyrosine kinase inhibitor that is targeted to act on the mutated c-kit of MCTs. Hmm … I hope I got that right. Basically, this class of targeted drugs are expected to inhibit [...]
